Cancer Crosslinks 2027 – Bridging Innovations to Improve Clinical Outcomes for Cancer Patients

The Cancer Crosslinks 2027 conference will take place on January 14, 2027, at the Kaare Norum Auditorium, Oslo Cancer Cluster Innovation Park, in Oslo, Norway.
Organized by Oslo Cancer Cluster, the 19th edition will focus on the theme “Bridging Innovations to Improve Clinical Outcomes for Cancer Patients.”
Established in 2009 by Oslo Cancer Cluster in collaboration with Bristol Myers Squibb, Cancer Crosslinks is an annual educational meeting connecting international oncology experts with Norwegian clinicians, researchers, and healthcare professionals. The conference provides a platform for discussing advances in cancer diagnostics and treatment, strengthening translational research, and encouraging collaboration between scientific and clinical communities.
The meeting will bring together oncologists, hematologists, translational researchers, healthcare providers, regulatory experts, patient representatives, and industry professionals. In addition to its educational program and networking opportunities, Cancer Crosslinks 2027 will feature the presentation of the Norwegian Cancer Society’s Innovation Award, recognizing contributions to cancer innovation.